Infectious Diseases News and Research

RSS

Mayo Clinic, 18 other leading research institutions urge Congress to maintain funding levels for NIH

Mayo Clinic and 18 other leading medical research institutions nationwide are urging congressional leaders to maintain current funding levels for the National Institutes of Health.

12 Jul 2012

SRI receives NIAID grant to develop HIV vaccine

The Scripps Research Institute has been awarded a grant expected to total more than $77 million from the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID).

12 Jul 2012

Dolutegravir-based regimen demonstrates superiority over Atripla in treatment-naive adults with HIV-1

Shionogi-ViiV Healthcare LLC today announced that initial results have been received from the Phase III SINGLE (ING114467) study of the investigational integrase inhibitor dolutegravir in treatment-naive adults with HIV-1.

12 Jul 2012

Ambulance crews failing to flag stroke arrivals

Two studies from the Get With The Guidelines–Stroke initiative show that the emergency medical services often fail to notify hospitals of an incoming stroke patient, despite the clear positive effect on acute stroke treatment.

11 Jul 2012

Microbiologists reveal how T. brucei’s key proteins organize to replicate its mtDNA

A group of diseases that kill millions of people each year can't be touched by antibiotics, and some treatment is so harsh the patient can't survive it. They're caused by parasites, and for decades researchers have searched for a "magic bullet" to kill them without harming the patient. Now, a team of microbiologists at the University of Massachusetts Amherst has made an advance that could one day lead to a new weapon for fighting parasitic diseases such as African sleeping sickness, chagas disease and leishmaniasis.

11 Jul 2012

Fatal outcome from HFMD is rare, says LUHS pediatric infectious disease specialist

A mysterious disease that has killed nearly 60 children in Cambodia has been identified by the World Health Organization as enterovirus 71. This virus is one among a family of viruses that cause a variety of illnesses, including a common childhood illness called hand, foot and mouth disease, but Andrew Bonwit, MD, pediatric infectious disease specialist at Loyola University Health System, says a fatal outcome from such illness is rare.

11 Jul 2012

HIV and AIDS treatment: An interview with Charles Flexner, MD

The best estimates at the moment reckon that there are about 25 million people infected with HIV. Most of those are in resource-limited settings, including sub-Saharan Africa, South East Asia and India.

11 Jul 2012

Broken heart syndrome arms against epinephrine high

Takotsubo cardiomyopathy, or “broken heart syndrome,” may actually protect the heart from very high levels of epinephrine, suggest results from an animal study.

10 Jul 2012

Seizure risk should not influence AVM treatment decisions

Choosing to treat patients with arteriovenous malformations surgically rather than conservatively has no bearing on their risk for seizures, suggest findings from the Scottish Audit of Intracranial Vascular Malformations.

10 Jul 2012

Laparoscopic appendectomy preferable for obese patients

Obese patients with appendicitis have fewer postoperative complications, a shorter stay in hospital, and shorter operative times when treated with laparoscopic appendectomy rather than open appendectomy, study findings show.

10 Jul 2012

Alcohol has toxic effect on critical care services

Alcohol may account for more than one in 10 emergency department admissions, a study from the UK suggests.

10 Jul 2012

COPD still affects treatment received after heart attack

Patients with chronic obstructive pulmonary disease receive less aggressive treatment after hospitalization for acute myocardial infarction than those without the lung condition, US study results show.

10 Jul 2012

Scientists identify novel strategy to target Taspase1 enzyme

Scientists at the University Medical Center of Johannes Gutenberg University Mainz in Germany identified a novel strategy to target the oncologically relevant protein-cleaving enzyme Taspase1.

10 Jul 2012

UCLA to examine whether copper surfaces result in reduced hospital infection rates

Hospital-acquired infections are a huge public health burden, and hospital environments play a key role in harboring potentially deadly bacteria such as E. coli, C. difficile and methicillin-resistant Staphylococcus aureus.

10 Jul 2012

Inovio commences SynCon vaccine phase I study in H1N1 influenza

Inovio Pharmaceuticals, Inc. announced today that the first patients have been treated in a clinical trial evaluating immune responses in elderly adults immunized with Inovio's H1N1 SynCon universal influenza vaccine.

10 Jul 2012

Associated Press examines 'sense of optimism' in HIV fight as AIDS 2012 conference approaches

Noting more than 20,000 international HIV researchers and activists will gather in Washington, D.C., for the AIDS 2012 conference later this month, the Associated Press writes that there is "a sense of optimism not seen in many years -- hope that it finally may be possible to dramatically stem the spread of the AIDS virus."

10 Jul 2012

Einstein researchers to study molecular mechanism behind Ebola virus infection

The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine of Yeshiva University a five-year, $4.8 million grant to study the molecular mechanism that allows the Ebola virus to cause infection and spread in animals.

10 Jul 2012

Prediction tool indicates prognosis after cardiac arrest

US researchers report the development of a prediction tool that could help determine neurologic prognosis after in-hospital cardiac arrest.

9 Jul 2012

PCV13 offers best overall protection from CAP in young children

Researchers have identified a pneumococcal conjugate vaccine that is effective for treating bacteremic pneumococcal community-acquired pneumonia in children aged 5 years or younger.

9 Jul 2012

Regnite to treat primary restless legs syndrome launched in Japan

Astellas Pharma Inc. and XenoPort, Inc. announced today that Regnite (gabapentin enacarbil) Extended-Release Tablets will be launched in Japan on July 10, 2012. Regnite is approved in Japan for the treatment of moderate-to-severe primary restless legs syndrome (RLS).

9 Jul 2012